Arena Pharmaceuticals Reports Q4 EPS of $(0.23) vs. $(0.21)

Arena Pharmaceuticals, Inc. ARNA today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments.

Arena reported a net loss in the fourth quarter of 2010 of $28.2 million, or $0.23 per share, compared to a net loss in the fourth quarter of 2009 of $29.8 million, or $0.32 per share, and a net loss in the full year ended December 31, 2010, of $124.5 million, or $1.14 per share, compared to a net loss in the full year ended December 31, 2009, of $153.2 million, or $1.82 per share.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!